TB morbidity estimates overlook the contribution of post-TB disability: evidence from urban Malawi
Open Access
- 20 May 2022
- journal article
- research article
- Published by BMJ in BMJ Global Health
- Vol. 7 (5) , e007643
Abstract
Introduction: Despite growing evidence of the long-term impact of tuberculosis (TB) on quality of life, Global Burden of Disease (GBD) estimates of TB-related disability-adjusted life years (DALYs) do not include post-TB morbidity, and evaluations of TB interventions typically assume treated patients return to pre-TB health. Using primary data, we estimate years of life lost due to disability (YLDs), years of life lost due to premature mortality (YLL) and DALYs associated with post-TB cardiorespiratory morbidity in a low-income country. Methods: Adults aged ≥15 years who had successfully completed treatment for drug-sensitive pulmonary TB in Blantyre, Malawi (February 2016–April 2017) were followed-up for 3 years with 6-monthly and 12-monthly study visits. In this secondary analysis, St George’s Respiratory Questionnaire data were used to match patients to GBD cardiorespiratory health states and corresponding disability weights (DWs) at each visit. YLDs were calculated for the study period and estimated for remaining lifespan using Malawian life table life expectancies. YLL were estimated using study mortality data and aspirational life expectancies, and post-TB DALYs derived. Data were disaggregated by HIV status and gender. Results: At treatment completion, 222/403 (55.1%) participants met criteria for a cardiorespiratory DW, decreasing to 15.6% after 3 years, at which point two-thirds of the disability burden was experienced by women. Over 90% of projected lifetime-YLD were concentrated within the most severely affected 20% of survivors. Mean DWs in the 3 years post-treatment were 0.041 (HIV-) and 0.025 (HIV+), and beyond 3 years estimated as 0.025 (HIV-) and 0.010 (HIV+), compared with GBD DWs of 0.408 (HIV+) and 0.333 (HIV-) during active disease. Our results imply that the majority of TB-related morbidity occurs post-treatment. Conclusion: TB-related DALYs are greatly underestimated by overlooking post-TB disability. The total disability burden of TB is likely undervalued by both GBD estimates and economic evaluations of interventions, particularly those aimed at early diagnosis and prevention.Keywords
Funding Information
- Programme Grants for Applied Research (16/136/35)
- Medical Research Council (MR/N013514/1, MR/S02042X/1)
- Wellcome Trust (106065/Z/14/A)
This publication has 40 references indexed in Scilit:
- Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general populationThe Lancet HIV, 2014
- A systematic review and meta-analysis of the impact of tuberculosis on health-related quality of lifeQuality of Life Research, 2012
- Health outcomes in economic evaluation: the QALY and utilitiesBritish Medical Bulletin, 2010
- Pulmonary impairment after tuberculosis and its contribution to TB burdenBMC Public Health, 2010
- High Rates of Recurrence in HIV‐Infected and HIV‐Uninfected Patients with TuberculosisThe Journal of Infectious Diseases, 2010
- Measuring health-related quality of life in tuberculosis: a systematic reviewHealth and Quality of Life Outcomes, 2009
- Cognitive impairment and preferences for current healthHealth and Quality of Life Outcomes, 2009
- Using the St. George Respiratory Questionnaire To Ascertain Health Quality in Persons With Treated Pulmonary TuberculosisChest, 2007
- Pulmonary tuberculosis: radiological features in west Africans coinfected with HIV.British Journal of Radiology, 1999
- A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory QuestionnaireAmerican Review of Respiratory Disease, 1992